We are upgrading our infrastructure for a faster experience. We appreciate your patience in the meantime.
Contact Seller for Price
航运是可控的Enquire Best Price to Buy Tofersen in India
About API Tofersen:
Qalsody (tofersen) is the first FDA-approved therapy developed for individuals with amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene. This targeted treatment is designed to address the underlying disease process involved in neurodegeneration and its progression. Granted accelerated approval by the FDA, Qalsody demonstrated a reduction in plasma neurofilament light chain (NfL) levels, a recognized biomarker associated with neuronal damage and injury.
超过1千元的免费航运!
Only logged in customers who have purchased this product may leave a review.
审查
There are no reviews yet.